Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 2, 2016, Pages 400-411

  Mitsui, Chihiro ^a,c   Kajiwara, Keiichi ^a   Hayashi, Hiroaki ^a   Ito, Jun ^a   Mita, Haruhisa ^a   Ono, Emiko ^a   Higashi, Noritaka ^a,b   Fukutomi, Yuma ^a   Sekiya, Kiyoshi ^a   Tsuburai, Takahiro ^a   Akiyama, Kazuo ^a   Yamamoto, Kazuhiko ^c   Taniguchi, Masami ^a  

^a SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^b JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

adhesion; aspirin exacerbated respiratory disease; asthma; cysteinyl leukotriene; P selectin; platelet

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; LEUKOTRIENE E4; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ASTHMA, ASPIRIN-INDUCED; COMORBIDITY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RESPIRATION DISORDERS; RISK FACTOR; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA, ASPIRIN-INDUCED; BIOMARKERS; BLOOD PLATELETS; COMORBIDITY; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; LEUKOTRIENE E4; MALE; MIDDLE AGED; PLATELET ACTIVATION; RESPIRATION DISORDERS; RISK FACTORS;

EID: 84957964842     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.05.041     Document Type: Article

References (50)

1. D.D. Stevenson, and A. Szczeklik Clinical and pathologic perspectives on aspirin sensitivity and asthma J Allergy Clin Immunol 118 2006 773 786
2. A. Szczeklik, E. Nizankowska, and M. Duplaga Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma Eur Respir J 16 2000 432 436
3. Y. Fukutomi, M. Taniguchi, T. Tsuburai, H. Tanimoto, C. Oshikata, E. Ono, and et al. Obesity and aspirin intolerance are risk factors for difficult-to-treat asthma in Japanese non-atopic women Clin Exp Allergy 42 2012 738 746
4. K. Mascia, T. Haselkorn, Y.M. Deniz, D.P. Miller, E.R. Bleecker, and L. Borish Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma J Allergy Clin Immunol 116 2005 970 975
5. H. Yamaguchi, N. Higashi, H. Mita, E. Ono, Y. Komase, T. Nakagawa, and et al. Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma Clin Exp Allergy 41 2011 1711 1718
6. T.M. Laidlaw, and J.A. Boyce Pathogenesis of aspirin-exacerbated respiratory disease and reactions Immunol Allergy Clin North Am 33 2013 195 210
7. M. Kumlin, B. Dahlen, T. Bjorck, O. Zetterstrom, E. Granstrom, and S.E. Dahlen Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics Am Rev Respir Dis 146 1992 96 103
8. N. Higashi, M. Taniguchi, H. Mita, Y. Kawagishi, T. Ishii, A. Higashi, and et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis J Allergy Clin Immunol 113 2004 277 283
9. P.E. Christie, P. Tagari, A.W. Ford-Hutchinson, C. Black, A. Markendorf, M. Schmitz-Schumann, and et al. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects Am Rev Respir Dis 146 1992 1531 1534
10. H. Mita, S. Endoh, M. Kudoh, Y. Kawagashi, M. Kobayashi, M. Taniguchi, and et al. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma Allergy 56 2001 1061 1067
11. A.S. Cowburn, K. Sladek, J. Soja, L. Adamek, E. Nizankowska, A. Szczeklik, and et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma J Clin Invest 101 1998 834 846
12. C. Page, and S. Pitchford Platelets and allergic inflammation Clin Exp Allergy 44 2014 901 913
13. D. Slater, J. Martin, and A. Trowbridge The platelet in asthma Lancet 1 1985 110
14. J. Jawien, M. Lomnicka, R. Korbut, and S. Chlopicki The involvement of adhesion molecules and lipid mediators in the adhesion of human platelets to eosinophils J Physiol Pharmacol 56 2005 637 648
15. N. Li Platelet-lymphocyte cross-talk J Leukoc Biol 83 2008 1069 1078
16. L.H. Ulfman, D.P. Joosten, C.W. van Aalst, J.W. Lammers, E.A. van de Graaf, L. Koenderman, and et al. Platelets promote eosinophil adhesion of patients with asthma to endothelium under flow conditions Am J Respir Cell Mol Biol 28 2003 512 519
17. Z. Zietkowski, R. Skiepko, M.M. Tomasiak, and A. Bodzenta-Lukaszyk Soluble CD40 ligand and soluble P-selectin in allergic asthma patients during exercise-induced bronchoconstriction J Investig Allergol Clin Immunol 18 2008 272 278
18. K. Kowal, A. Pampuch, O. Kowal-Bielecka, L.M. DuBuske, and A. Bodzenta-Lukaszyk Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus Clin Exp Allergy 36 2006 426 432
19. K. Kowal, A. Pampuch, O. Kowal-Bielecka, L. Iacoviello, and A. Bodzenta-Lukaszyk Soluble CD40 ligand in asthma patients during allergen challenge J Thromb Haemost 4 2006 2718 2720
20. T.M. Laidlaw, M.S. Kidder, N. Bhattacharyya, W. Xing, S. Shen, G.L. Milne, and et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes Blood 119 2012 3790 3798
21. M.L. Kowalski, I. Grzelewska-Rzymowska, J. Rozniecki, and M. Szmidt Aspirin tolerance induced in aspirin-sensitive asthmatics Allergy 39 1984 171 178
22. A.P. Hope, K.A. Woessner, R.A. Simon, and D.D. Stevenson Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease J Allergy Clin Immunol 123 2009 406 410
23. V. Bertele, A. Falanga, M. Tomasiak, E. Dejana, C. Cerletti, and G. de Gaetano Platelet thromboxane synthetase inhibitors with low doses of aspirin: possible resolution of the "aspirin dilemma" Science 220 1983 517 519
24. M.L. Capone, S. Tacconelli, M.G. Sciulli, M. Grana, E. Ricciotti, P. Minuz, and et al. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects Circulation 109 2004 1468 1471
25. W.W. Pleskow, D.D. Stevenson, D.A. Mathison, R.A. Simon, M. Schatz, and R.S. Zeiger Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period J Allergy Clin Immunol 69 1982 11 19
26. A. Taytard, H. Guenard, L. Vuillemin, J.L. Bouvot, J. Vergeret, D. Ducassou, and et al. Platelet kinetics in stable atopic asthmatic patients Am Rev Respir Dis 134 1986 983 985
27. D.D. Stevenson, W.W. Pleskow, R.A. Simon, D.A. Mathison, W.R. Lumry, M. Schatz, and et al. Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin J Allergy Clin Immunol 73 1984 500 507
28. K. Fruth, B. Pogorzelski, I. Schmidtmann, J. Springer, N. Fennan, N. Fraessdorf, and et al. Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease Allergy 68 2013 659 665
29. D.D. Stevenson Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs J Allergy Clin Immunol 74 1984 617 622
30. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society Am J Respir Crit Care Med 162 2000 2341 2351
31. J.N. Allen, and W.B. Davis Eosinophilic lung diseases Am J Respir Crit Care Med 150 1994 1423 1438
32. H. Mita, R. Oosaki, Y. Mizushima, M. Kobayashi, and K. Akiyama Efficient method for the quantitation of urinary leukotriene E4: extraction using an Empore C18 disk cartridge J Chromatogr B Biomed Sci Appl 692 1997 461 466
33. A.D. Michelson, M.R. Barnard, H.B. Hechtman, H. MacGregor, R.J. Connolly, J. Loscalzo, and et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function Proc Natl Acad Sci U S A 93 1996 11877 11882
34. J.A. Maclouf, and R.C. Murphy Transcellular metabolism of neutrophil-derived leukotriene A4 by human platelets. A potential cellular source of leukotriene C4 J Biol Chem 263 1988 174 181
35. P. Patrignani, and M. Dovizio Inside platelet-leukocyte cross-talk Blood 119 2012 3649 3650
36. H.E. Cummings, T. Liu, C. Feng, T.M. Laidlaw, P.B. Conley, Y. Kanaoka, and et al. Cutting edge: leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor J Immunol 191 2013 5807 5810
37. S. Paruchuri, H. Tashimo, C. Feng, A. Maekawa, W. Xing, Y. Jiang, and et al. Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor J Exp Med 206 2009 2543 2555
38. T.M. Laidlaw, A.J. Cutler, M.S. Kidder, T. Liu, J.C. Cardet, H. Chhay, and et al. Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease J Allergy Clin Immunol 133 2014 1692 1701
39. D.P. Inwald, A. McDowall, M.J. Peters, R.E. Callard, and N.J. Klein CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation Circ Res 92 2003 1041 1048
40. E. Ono, M. Taniguchi, H. Mita, N. Higashi, Y. Fukutomi, H. Tanimoto, and et al. Increased urinary leukotriene E4 concentration in patients with eosinophilic pneumonia Eur Respir J 32 2008 437 442
41. E.L. Doyle, V. Ridger, F. Ferraro, M. Turmaine, P. Saftig, and D.F. Cutler CD63 is an essential cofactor to leukocyte recruitment by endothelial P-selectin Blood 118 2011 4265 4273
42. S.C. Pitchford, H. Yano, R. Lever, Y. Riffo-Vasquez, S. Ciferri, M.J. Rose, and et al. Platelets are essential for leukocyte recruitment in allergic inflammation J Allergy Clin Immunol 112 2003 109 118
43. E. Nizankowska, G. Czerniawska-Mysik, and A. Szczeklik Lack of effect of i.v. prostacyclin on aspirin-induced asthma Eur J Respir Dis 69 1986 363 368
44. S. Palikhe, N.S. Palikhe, S.H. Kim, H.S. Yoo, Y.S. Shin, and H.S. Park Elevated platelet activation in patients with chronic urticaria: a comparison between aspirin-intolerant and aspirin-tolerant groups Ann Allergy Asthma Immunol 113 2014 276 281
45. S. Tornhamre, A. Ehnhage, K.G. Kolbeck, C. Edenius, and J.A. Lindgren Uncoupled regulation of leukotriene C4 synthase in platelets from aspirin-intolerant asthmatics and healthy volunteers after aspirin treatment Clin Exp Allergy 32 2002 1566 1573
46. U. Klinkhardt, J. Graff, and S. Harder Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model Clin Pharmacol Ther 71 2002 176 185
47. A. Caron, J.F. Theoret, S.A. Mousa, and Y. Merhi Anti-platelet effects of GPIIb/IIIa and P-selectin antagonism, platelet activation, and binding to neutrophils J Cardiovasc Pharmacol 40 2002 296 306
48. A.E. John, N.W. Lukacs, A.A. Berlin, A. Palecanda, R.F. Bargatze, L.M. Stoolman, and et al. Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease FASEB J 17 2003 2296 2298
49. R.T. Amison, S. Momi, A. Morris, G. Manni, S. Keir, P. Gresele, and et al. Rho A signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice J Allergy Clin Immunol 135 2015 528 538
50. J.R. McDonald, E.M. Tan, D.D. Stevenson, and J.H. Vaughan Platelet aggregation in asthmatic and normal subjects J Allergy Clin Immunol 54 1974 200 208